Covalon Technologies (CVE:COV) Stock Price Down 2.4%

-day trading, a decline of 98% from the average daily volume of 217,213 shares. The stock had previously closed at C$2.06. The stock of Covalon Technologies Ltd. declined 2.4% on Tuesday. The company traded as low as C$2.00 and last traded at C$2.00. Approximately 5,300 shares changed hands during

On Tuesday, ) shares fell 2.4%. The company traded from C$2.00 to C$2.00, and lasted traded at C$2.00. Around 5,300 shares were traded during the mid-day period, which is a 34% decrease from the daily average of 8,004 stocks. The stock closed the previous day at C$2.05

Covalon Technologies Price Performance

The company's debt-to equity ratio is 8.52, its quick ratio is 6.45, and its current ratio is 5.21. The stock's simple moving 50-day average is C$2.12; its simple 200-day moving average C$2.22. The company released its last earnings report on Wednesday, 25th January. The company reported C ($0.16) per share earnings for the quarter. Covalon Technologies reported a negative return of equity of 31.05 % and a net margin of 44.96 %. The company generated revenue of C$5.39m during the third quarter. Sell-side analysts predict that Covalon Technologies Ltd. is expected to post 0.3 earnings per share for the current fiscal year.

Covalon Technologies

Get Rating

Covalon Technologies Ltd. develops and manufactures medical products and technologies in North America, Europe, Asia, Latin America and the Middle East. Covalon Technologies Ltd. has three proprietary platform technologies. These include collagen matrix platform which is used in the manufacture of a family products for treating chronic and infected injuries, such as diabetic ulcers and pressure ulcers. It also includes donor and graft site products, traumatic and surgical wounds that heal by secondary intention and dehisced wounds. offers a FREE daily email newsletter